BMN 673 (Talazoparib) Yüklü Katı Lipid Nanopartikül (KLN) Formülasyonu


Çeçener G., Tunca B., Egeli Ü., Güney Eskiler G., Dikmen G.

Patent, CHAPTER A Human Needs, The Invention Recourse Number: 2017/14474 , Standard Registration, 2017, Pending / Applied

  • Intellectual Property: Patent
  • Country/Organization of Application: Turkey
  • Status of The Invention: Pending / Applied
  • Recourse Date: 9/28/2017